AMWL - NYSE
American Well Corporation
$8.50
+5.1%American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care. The company also provides telemedicine equipment, including telemedicine carts, peripherals, tyto care, TV kits, tablets, and kiosks. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
At a Glance
Live SnapshotAmerican Well Corporation Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Moderate conversion rate. Some gap between earnings and cash flow may warrant investigation into working capital or non-cash items.
CapEx Intensity
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
FCF Growth Trend
Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.
Working Capital Impact
Moderate working capital outflow. Typical for growing businesses, but ensure it's supporting revenue growth, not inefficiency.
Cash Flow Quality Insight
Working capital strain: Significant cash tied up in operations. Monitor receivables collection, inventory turns, and payment terms to optimize cash conversion cycle.
American Well Corporation Cash Flow Statement
AMWL • NYSE
| American Well Corporation Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | ||||||||
-95.7M | -208.1M | -675.2M | -272.1M | -176.8M | -228.6M | -88.4M | -52.3M | |
34M | 33.4M | 31.9M | 26.2M | 16.1M | 10.2M | 7.8M | 5.3M | |
-1.1M | -243K | -242K | -2.5M | -6.2M | 3.8M | -1.4M | 884K | |
22M | 0.0 | 72.2M | 67.7M | 43.8M | 118.4M | 12.1M | 7.7M | |
1.7M | 57.6M | 438.4M | 16.5M | 9.3M | 2.3M | 2.5M | 1.2M | |
(0.0) | (4.1M) | (5M) | (1.7M) | (1.6M) | (713K) | (193K) | (0.0) | |
-26.8M | -10M | -15.5M | -28.1M | -27.7M | -18.4M | -14.5M | -36.8M | |
-66M | -127.3M | -148.3M | -192.3M | -141.5M | -112.5M | -81.9M | -74M | |
INVESTING ACTIVITIES | ||||||||
-21K | (0.0) | -292K | -10.4M | -559K | -3.3M | -1.3M | -1.9M | |
(18.3M) | (0.0) | (0.0) | -2M | -159.1M | -2.9M | -45.8M | -64.4M | |
-1M | (0.0) | -390M | -499.2M | (2.5M) | -159.6M | -78.9M | -355.2M | |
0.0 | 0.0 | 390M | 500M | 100M | 99.1M | 246M | 175.6M | |
-196K | -18.7M | -18.9M | 0.0 | -2.5M | 0.0 | 167.1M | -179.6M | |
(17.1M) | -18.7M | -19.2M | -11.6M | -59.6M | -66.8M | (120M) | -245.9M | |
FINANCING ACTIVITIES | ||||||||
840K | -3K | -586K | -360K | -15M | 834.5M | -158K | 0.0 | |
-4K | -3K | -586K | -360K | -15M | -37.6M | -158K | -2.9M | |
0.0 | 1.4M | 2.7M | -3.3M | 20.8M | 2.6M | 1M | 635K | |
840K | 1.4M | 2.1M | -3.6M | 5.8M | 983.1M | 46.6M | 278.2M | |
CASH FLOW SUMMARY | ||||||||
2M | 887K | -1.1M | -305K | -84K | 0.0 | 0.0 | 0.0 | |
-46M | -143.7M | -166.5M | -207.9M | -195.5M | 803.9M | 84.7M | -41.8M | |
229.1M | 372.8M | 539.3M | 747.2M | 942.7M | 138.8M | 54.1M | 95.8M | |
183.1M | 229.1M | 372.8M | 539.3M | 747.2M | 942.7M | 138.8M | 54.1M | |
-66M | -142.6M | -163.6M | -202.8M | -142.1M | -115.8M | -83.2M | -75.9M |
SEC Filings
AMWL - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 12, 2026 | May 06, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 05, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 05, 2026 | May 05, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 23, 2026 | April 23, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 02, 2026 | April 01, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 12, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 12, 2026 | February 12, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 08, 2026 | January 05, 2026 | 2026 | |
8-K 8-K 2025 N/A | January 02, 2026 | December 24, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | November 04, 2025 | September 30, 2025 | 2025 |
Related Guides
Continue your AMWL research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.